CD1D and neoplasm: In fact, by targeting immune-suppressive myeloid cells via CD1d, recruiting cytotoxic T and NK cells, and activating APCs, iNKTs can create the conditions necessary for tumor eradication in solid malignancies and lymphoproliferative solid-like neoplasms (64, 67, 69–71).